Aspirin or clopidogrel after heart transplant
Treatments studied
Part of Heart & circulation clinical trials.
This study tests antiplatelet medicines (like aspirin or clopidogrel) in people who have had a heart transplant. The goal is to see if these medicines can safely help prevent blood-related complications after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a heart transplant
- You are 18 years or older
- You can understand the study and sign consent
- You do not have known allergy or intolerance to aspirin or clopidogrel
- You have not had recent bleeding in the brain (within the last 14 days)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to managing anti-rejection medicines after a heart transplant. It uses special blood tests to see if your immune system is calm, so doctors can safely reduce the medicines and lower side effects.
This study looks at using two anti-rejection medicines (everolimus and a lower dose of a calcineurin inhibitor) after a heart transplant. The goal is to see if this combination is safe and effective for keeping your body from rejecting the new heart, while possibly protecting your kidneys compared to standard treatment.
This study tests a drug called belatacept, which may help prevent the body from rejecting a new heart. It is given after a heart transplant, and the goal is to see if it works as well as or better than standard anti-rejection medicines.
This trial measures how well tiny blood vessels in the heart are working in people who have had a heart transplant. It may help doctors understand transplant-related circulation problems and guide future care.
This study investigates a new heart scan (called a cardiac PET) to detect early signs of blood vessel disease in heart transplant patients. If you had your transplant 2 to 10 years ago, this scan might be an alternative to the usual yearly checkup with an invasive procedure (angiogram).
This trial studies whether belatacept can be used after a heart transplant to help protect kidney function over time. It focuses on people who already have (or are at risk for) worsening kidney function after transplant, while avoiding those with certain infections or rejection concerns.
Hear when a new Cardiac Allograft Vasculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.